SARMs & Risk
SARMs — selective androgen receptor modulators — are marketed with an irresistible promise: the muscle of steroids, without the downsides. It's worth examining that promise honestly, because it mostly doesn't hold.
SARMs are compounds designed to stimulate androgen receptors more selectively than testosterone — the theory being you'd get muscle and bone effects with fewer effects elsewhere. That's the theory. In practice, the "selectivity" is incomplete, and the real-world picture is far messier than the pitch.
Analyses of products sold as SARMs have repeatedly found a large proportion are mislabelled — containing different compounds, unapproved drugs, or wildly different amounts than the label claims. Regulators (including the FDA) have issued warnings specifically about SARMs in supplements. So even setting aside the molecule, you frequently don't know what you're actually taking.
SARMs are best understood not as a clever loophole but as unapproved drugs with real risks and an unreliable supply, wrapped in marketing that downplays both. The "safer steroid" framing is the product of selling, not science. If your goal is muscle, the boring truth holds: training, protein, sleep and recovery, plus not being hormonally deficient, are the biggest, safest, most reliable levers.
The pitch behind SARMs is genuinely clever in theory. Testosterone activates androgen receptors everywhere — muscle, but also skin, prostate, hair follicles and more — which is why steroids cause such wide-ranging effects. SARMs were designed to bind androgen receptors more selectively, ideally switching on muscle and bone growth while leaving other tissues alone. If that worked perfectly, you'd get steroid-like muscle with far fewer side effects. That's the promise on every sales page.
In practice, the selectivity is incomplete. Real-world SARMs still affect the broader system: many users see meaningful suppression of their own testosterone — the same axis shutdown that steroids cause — along with changes to cholesterol and, in documented cases, liver injury. "More selective than testosterone" is not the same as "safe," and the gap between the elegant theory and the messy reality is where users get hurt.
Regulators and clinicians have linked SARMs to suppressed testosterone, liver toxicity (including reported cases of significant liver injury in young, healthy users), adverse cholesterol and cardiovascular markers, and more. Crucially, because they've never completed full human safety trials, the long-term risks are simply unknown — nobody can honestly tell you what years of use do, because that research doesn't exist.
Even setting aside the molecule, there's a supply problem. Independent analyses of products sold as SARMs have repeatedly found a large proportion are mislabelled — containing different compounds, undeclared drugs (sometimes actual anabolic steroids), additional unlisted substances, or wildly different amounts than the label claims. So a buyer often doesn't truly know what they're taking, at what dose. That uncertainty alone makes informed risk-taking nearly impossible.
SARMs are frequently sold labelled "for research use only," yet the same sites list bodybuilding dosages and cycles — a transparent loophole to sidestep the fact that they're not approved for human consumption. Regulators including the FDA have specifically warned that SARMs in bodybuilding products carry serious risks and shouldn't be used. The honest verdict: SARMs are best understood as unapproved drugs with real, partly-unknown risks and an unreliable supply — the "safer steroid" label is marketing, not science.
The Testosterone Blueprint is the science-based guide to optimising your testosterone naturally — no guesswork, no gym myths.
Get the book →